Pharma

FDA approves Lilly's Mounjaro to reduce risk of cardio events

The FDA has signed off on a label expansion for Eli Lilly's Mounjaro to reduce the risk of heart attack or stroke in at-risk adults with type 2 diabetes.

Kevin Dunleavy Aug 28, 2026 10:52am

showdown clash versus vs crash lightning fight dispute

The Oral GLP-1 Tracker: Lilly's Foundayo scripts cross 40K

Aug 28, 2026 9:30am

When is the new who The importance of timing in HCP marketing

When is the new who in HCP marketing

Brought to you by Phreesia Network Solutions

Fierce Biotech

Teva saddles up as bidder for bankrupt BioXcel’s CNS assets

Aug 28, 2026 9:17am

Designing an agentic, future‑ready tech roadmap for emerging pharma

Brought to you by ZS

Roche-Hanmi, Akeso, a congressman's concerns—Fierce Pharma Asia

Aug 28, 2026 9:00am